BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ezquerra-Aznárez JM, Degiacomi G, Gašparovič H, Stelitano G, Sammartino JC, Korduláková J, Governa P, Manetti F, Pasca MR, Chiarelli LR, Ramón-García S. The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme. Int J Mol Sci 2022;23:771. [PMID: 35054958 DOI: 10.3390/ijms23020771] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Degiacomi G, Makarov V, Pasca MR, Chiarelli LR. New Drugs and Novel Cellular Targets against Tuberculosis. Int J Mol Sci 2022;23. [PMID: 36430162 DOI: 10.3390/ijms232213680] [Reference Citation Analysis]
2 Amado PSM, Woodley C, Cristiano MLS, O’neill PM. Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties. ACS Omega 2022. [DOI: 10.1021/acsomega.2c05307] [Reference Citation Analysis]